The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Acta Diabetologica

• Publication date

  2025-11-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00592-025-02592-2PMID 41212214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Automated insulin delivery during the first six months postpartum: pre-specified AiDAPT extension study

  2025cited by this paper
• Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis

  2025cited by this paper
• Use of the temporary glycemic target feature in the medtronic MiniMed™ 780G advanced hybrid closed loop system: a real-world evidence study

  2025cited by this paper
• Provider Perspective on Automated Insulin Devices in Pregnancy and Considerations for Implementation in Clinical Practice

  2025cited by this paper
• Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.

  2025cited by this paper
• Navigating Automated Insulin Delivery for Type 1 Diabetes Management During Pregnancy

  2025cited by this paper
• Tips for successful use of commercial automated insulin delivery systems: An expert paper of the Italian working group on diabetes and technology.

  2025cited by this paper
• Impact of Automated Insulin Delivery on Glycemic Profile and Maternal/Neonatal Outcomes in Pregnancy: A Review of the Evidence From Observational Studies

  2025cited by this paper
• Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes

  2025cited by this paper
• Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021

  2025cited by this paper
• Technology advances in diabetes pregnancy: right technology, right person, right time

  2024cited by this paper
• Smart Insulin Pen in Pregnant Women with Type 1 Diabetes: An Encouraging Case Series

  2024cited by this paper
• 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2025.

  2024cited by this paper
• Advanced Hybrid Closed-Loop Therapy Compared With Standard Insulin Therapy Intrapartum and Early Postpartum in Women With Type 1 Diabetes: A Secondary Observational Analysis From the CRISTAL Randomized Controlled Trial.

  2024cited by this paper
• Women's and Partners' Experiences with a Closed-Loop Insulin Delivery System to Manage Type 1 Diabetes in the Postpartum Period.

  2024cited by this paper
• Safety of options to ″Boost″ (enhancing insulin infusion rates) and ″Ease-off″ (reducing insulin infusion rates) in CamAPS FX Hybrid Closed-Loop system: a real-world analysis

  2024cited by this paper
• Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes

  2024cited by this paper
• An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients

  2024cited by this paper
• Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus.

  2024cited by this paper
• Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.

  2024cited by this paper
• Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes.

  2024cited by this paper
• Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes

  2024cited by this paper
• Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where Do We Stand?

  2024cited by this paper
• Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System

  2023cited by this paper
• Real‐world use of Control‐IQ™ technology automated insulin delivery in pregnancy: A case series with qualitative interviews

  2023cited by this paper
• A Randomized Trial of Closed-Loop Insulin Delivery Postpartum in Type 1 Diabetes

  2023cited by this paper
• Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes

  2023cited by this paper
• Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.

  2023cited by this paper
• Listening to Women: Experiences of Using Closed-Loop in Type 1 Diabetes Pregnancy

  2023cited by this paper
• Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.

  2023cited by this paper
• Advantages of sensor‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus

  2023cited by this paper
• Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis

  2023cited by this paper
• MAGIC (maternal glucose in pregnancy) understanding the glycemic profile of pregnancy, intensive CGM glucose profiling and its relationship to fetal growth: an observational study protocol

  2023cited by this paper
• Intrapartum Continuous Subcutaneous Insulin Infusion versus Intravenous Insulin Infusion among Pregnant Individuals with Type 1 Diabetes Mellitus: A Randomized Controlled Trial.

  2023cited by this paper
• Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study

  2023cited by this paper
• The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization

  2023cited by this paper
• At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study

  2023cited by this paper
• Sensor augmented pump therapy with predictive suspension function for low glucose levels reduces time in hypoglycaemia in pregnant women with type 1 diabetes

  2023cited by this paper
• Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

  2023cited by this paper
• Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial

  2023cited by this paper
• Efficacy of Continuous Glucose Monitoring on Glycaemic Control in Pregnant Women with Gestational Diabetes Mellitus—A Systematic Review

  2022cited by this paper
• Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P Study

  2022cited by this paper
• Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes

  2022cited by this paper
• The Review of Insulin Pens—Past, Present, and Look to the Future

  2022cited by this paper
• Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

  2022cited by this paper
• Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy.

  2022cited by this paper
• Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes

  2022cited by this paper
• Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes

  2021cited by this paper
• The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial

  2021cited by this paper
• Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes

  2021cited by this paper
• Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy

  2021cited by this paper
• New closed-loop insulin systems

  2021cited by this paper
• Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.

  2021cited by this paper
• Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.

  2021cited by this paper
• Use of Virtual Care for Glycemic Management in People With Types 1 and 2 Diabetes and Diabetes in Pregnancy: A Rapid Review.

  2021cited by this paper
• The effects of the instantaneous scanning glucose monitoring system on hypoglycemia, weight gain, and health behaviors in patients with gestational diabetes: a randomised trial.

  2021cited by this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.

  2021cited by this paper
• Exploratory Analysis of Glycemic Control and Variability Over Gestation Among Pregnant Women with Type 1 Diabetes

  2021cited by this paper
• Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes

  2021cited by this paper
• Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial

  2021cited by this paper
• Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System

  2021cited by this paper
• Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes

  2021cited by this paper
• Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes

  2021cited by this paper
• Open-source automated insulin delivery systems for the management of type 1 diabetes during pregnancy

  2021cited by this paper
• Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta‐analysis of randomized clinical trials

  2021cited by this paper
• Comparison of intrapartum glycemic management strategies in pregnant women with type 1 diabetes mellitus

  2021cited by this paper
• Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.

  2020cited by this paper
• Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes

  2020cited by this paper
• Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP).

  2020cited by this paper
• Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes

  2020cited by this paper
• Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes

  2020cited by this paper
• Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

  2020cited by this paper
• Why #WeAreNotWaiting—Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey

  2020cited by this paper
• Commercialized Hybrid Closed-Loop System (Minimed Medtronic 670G) Results During Pregnancy

  2020cited by this paper
• Hybrid closed‐loop therapy: Where are we in 2021?

  2020cited by this paper
• A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System

  2020cited by this paper
• Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes

  2020cited by this paper
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

  2019cited by this paper
• Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology

  2019cited by this paper
• Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.

  2019cited by this paper
• Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

  2019cited by this paper
• Real-Time Continuous Glucose Monitoring in Gestational Diabetes: A Randomized Controlled Trial

  2019cited by this paper
• Continuous Glucose Monitor Use With Remote Monitoring Reduces Fear of Hypoglycemia in Pregnant Women With Type 1 Diabetes: A Pilot Study

  2019cited by this paper
• Case series of a hybrid closed‐loop system used in pregnancies in clinical practice

  2019cited by this paper
• The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.

  2019cited by this paper
• Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.

  2018cited by this paper
• Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.

  2018cited by this paper
• Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial

  2018cited by this paper
• Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange

  2018cited by this paper
• Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial

  2018cited by this paper
• Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes

  2018cited by this paper
• Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin‐treated gestational diabetes: a randomized controlled trial

  2018cited by this paper
• Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial

  2018cited by this paper
• Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

  2017cited by this paper
• Maternal–Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy

  2017cited by this paper
• Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study

  2017cited by this paper
• Experiences of closed‐loop insulin delivery among pregnant women with Type 1 diabetes

  2017cited by this paper
• Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.

  2016cited by this paper
• Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes

  2016cited by this paper
• Effect of a CGMS and SMBG on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus: a Randomized Controlled Trial

  2016cited by this paper

• Chrono-Nutrition in Gestational Diabetes Mellitus: Implications of Meal Timing and Nutrient Distribution for Glycemic Control

  2026cites this paper